Extracorporeal Photopheresis (ECP) at Centre of Advanced Medicine, Frankfurt, Germany

9.30

Frankfurt am Main, Germany

Overview

Age group

Kids, Adults

Type of care

Outpatient

Method

Non-surgical

About the offer

Extracorporeal Photopheresis (ECP) is a unique therapy combining immunomodulation and phototherapy to treat various autoimmune, inflammatory, and transplant-related diseases. Its mechanism of action not only targets abnormal immune cells but also reprograms the immune system, making it more tolerant and less aggressive toward the body's tissues. Additionally, ECP enhances T-regulatory cell activity, which helps balance immune responses and prevents excessive inflammation. The treatment has significantly improved skin symptoms in autoimmune diseases, especially in cutaneous T-cell lymphoma (CTCL) and scleroderma. Furthermore, recent studies suggest that ECP can improve microcirculation and wound healing, making it a promising therapy for diabetic ulcers and vascular disorders. The non-invasive procedure has a favorable safety profile, making it suitable for long-term management of chronic conditions without severe side effects. Ongoing research is exploring its role in neurodegenerative diseases like Alzheimer's and ALS, as well as cardiovascular disorders and chronic inflammatory conditions, potentially expanding the spectrum of treatable diseases. Additional information about Extracorporeal Photopheresis (ECP) includes its role in supporting organ transplantation, particularly for patients with heart or lung transplants who suffer from chronic rejection. ECP helps improve graft survival by reducing immune-mediated damage without the heavy side effects of immunosuppressive drugs. Moreover, ECP therapy has shown potential in treating psoriasis, atopic dermatitis, and pemphigus vulgaris. It is also considered in clinical trials for certain chronic viral infections like HIV. The treatment's dual action—suppressing harmful immune cells while enhancing immune tolerance—makes it a versatile option in both hematological and non-hematological diseases.

What’s included

Medical service

Examination

clinical history-taking
medical records review
physical examination
consultation with a renerative medicine specialist

Laboratory tests

complete blood count (CBC)
inflammation blood tests
biochemical analysis of blood

Treatment

pre-procedure patient preparation
blood collection
white blood cells separated, treated with methoxsalen, exposed to UV light
reinfused into the patient's body
postprocedure care
control examinations
symptomatic treatment

Other

cost of essential medicines
cost of essential materials
outpatient admission
nursing service
discharge medical records
further recommendations

Extra add-ons

Airport transfer

Personal coordinator

HealthDocs translate

Language Assistance

Visa Support

AiroCare

AiroMedical support

Payment protection

Patient advocacy

Price match

Meet the provider

Dr. med. Gerhard Siebenhuner

holistic and regenerative medicine, biological cancer therapy and complementary oncology, anti-aging

9.30

Excellent

Gallery

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

Location

Vilbeler Landstraße 45B, 60388 Frankfurt am Main, Germany

FAQ

Is Extracorporeal Photopheresis (ECP) effective?

Yes, ECP has proven effective for treating conditions like graft-versus-host disease (GvHD), systemic scleroderma, Crohn’s disease, autoimmune diseases, and various skin disorders, significantly reducing symptoms and improving quality of life.

How does ECP work?

ECP works by collecting white blood cells, treating them with a photosensitizing agent, and exposing them to UV light. This alters the cells and reintroduces them into the body to regulate immune responses, reduce inflammation, and promote healing.

Who can benefit from ECP therapy?

ECP therapy is used for patients with autoimmune diseases, chronic inflammatory conditions, GvHD, and some forms of cancer, including cutaneous T-cell lymphoma (CTCL).